483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial.
Bridgewater, J Pugh, S Whitehead, A Stanton, L Eminton, Z Mellor, J Allen, A Finch-Jones, M Falk, S Iveson, T
Bridgewater, J
Pugh, S
Whitehead, A
Stanton, L
Eminton, Z
Mellor, J
Allen, A
Finch-Jones, M
Falk, S
Iveson, T
Citations
Altmetric:
Abstract
Authors
Bridgewater, J
Pugh, S
Whitehead, A
Stanton, L
Eminton, Z
Mellor, J
Allen, A
Finch-Jones, M
Falk, S
Iveson, T
Rees, M
Valle, Juan W
Hornbuckle, J
Hickish, T
Cunningham, D
Maughan, T
Garden, J
Griffiths, G
Primrose, J
Pugh, S
Whitehead, A
Stanton, L
Eminton, Z
Mellor, J
Allen, A
Finch-Jones, M
Falk, S
Iveson, T
Rees, M
Valle, Juan W
Hornbuckle, J
Hickish, T
Cunningham, D
Maughan, T
Garden, J
Griffiths, G
Primrose, J
Affiliation
Oncology, UCL Cancer Institute/Paul O’Gorman Building, London
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial. 2017, 28(suppl_5): Ann Oncol